For: | Bhangal R, Cancarevic I, Nassar M, Umar Z. Impact of erythropoietin therapy on cardiorenal syndrome: A systematic review with meta-analysis. World J Cardiol 2023; 15(5): 273-283 [PMID: 37274373 DOI: 10.4330/wjc.v15.i5.273] |
---|---|
URL: | https://www.wjgnet.com/1949-8462/full/v15/i5/273.htm |
Number | Citing Articles |
1 |
Massimo Montalto, Federica D’Ignazio, Sara Camilli, Silvino Di Francesco, Marco Fedele, Francesco Landi, Antonella Gallo. Heart Failure in Older Patients: An Update. Journal of Clinical Medicine 2025; 14(6): 1982 doi: 10.3390/jcm14061982
|
2 |
Hideki Yokoi. Renal interstitial hydrostatic pressure: a culprit of pericyte detachment in renal congestion. Hypertension Research 2024; 47(2): 553 doi: 10.1038/s41440-023-01517-2
|
3 |
Lulu Fan, Lujia Cao, Yangyan Luo, Fang Gao. Roxadustat combined with immunosuppressants for treatment of pure red cell aplasia with kidney injury. Annals of Hematology 2024; 103(12): 5925 doi: 10.1007/s00277-024-06053-8
|
4 |
Xiaosheng Jin, Weijing Jin, Guoping Li, Jisheng Zheng, Xianrong Xu. Erythropoietin alleviates lung ischemia-reperfusion injury by activating the FGF23/FGFR4/ERK signaling pathway. PeerJ 2024; 12: e17123 doi: 10.7717/peerj.17123
|
5 |
Xiang Li, Xi Qin, Xiaoxi Zhang, Xuepu Li, Yong Zhou, Chenggang Liang. Advancing erythropoietin charge heterogeneity characterization by integrating ion exchange chromatography and imaged capillary isoelectric focusing coupled with online high-resolution mass spectrometry detection. Journal of Pharmaceutical and Biomedical Analysis 2025; : 117030 doi: 10.1016/j.jpba.2025.117030
|